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Previously, we have identified a large gene (lifA, for lymphocyte inhibitory factor A) in enteropathogenic
Escherichia coli (EPEC) encoding a protein termed lymphostatin that suppresses cytokine expression in vitro.
This protein also functions as an adhesion factor for enterohemorrhagic E. coli (EHEC) and Shiga toxin-
producing E. coli and is alternatively known as efa1 (EHEC factor for adherence 1). The lifA/efa1 gene is also
present in Citrobacter rodentium, an enteric pathogen that causes a disease termed transmissible murine colonic
hyperplasia (TMCH), which induces colitis and massive crypt cell proliferation, in mice. To determine if
lifA/efa1 is required for C. rodentium-induced colonic pathology in vivo, three in-frame mutations were gener-
ated, disrupting the glycosyltransferase (GlM12) and protease (PrMC31) motifs and a domain in between that
does not encode any known activity (EID3). In contrast to infection with wild-type C. rodentium, that with any
of the lifA/efa1 mutant strains did not induce weight loss or TMCH. Enteric infection with motif mutants
GlM12 and PrM31 resulted in significantly reduced colonization counts during the entire 20-day course of
infection. In contrast, EID3 was indistinguishable from the wild type during the initial colonic colonization, but
cleared rapidly after day 8 of the infection. The colonic epithelium of all infected mice displayed increased
epithelial regeneration. However, significantly increased regeneration was observed by day 20 only in mice
infected with the wild-type in comparison to those infected with lifA/efa1 mutant EID3. In summary, lifA/efa1
is a critical gene outside the locus for enterocyte effacement that regulates bacterial colonization, crypt cell
proliferation, and epithelial cell regeneration.
Citrobacter rodentium is a gram-negative bacterium that col-
onizes predominantly the distal colon of mice, causing a dis-
ease termed transmissible murine colonic hyperplasia
(TMCH), which induces colitis and crypt cell proliferation
(24). Colonic pathology in infected animals is characterized by
massive proliferation of crypt cells, goblet cell depletion, epi-
thelial cell disruption, and mucosal thickening from inflamma-
tion. Infected mice lose weight and develop ruffled fur and soft
fecal pellets, but usually do not have diarrhea. Depending on
the genetic background of the animals, mice clear the infection
within 4 weeks and recover completely by week 6.
C. rodentium belongs to a family of enteric gram-negative
bacteria that cause attaching and effacing (A/E) lesions char-
acterized by the accumulation of filamentous actin beneath the
site of bacterial attachment and loss of microvilli (34). Addi-
tional members of this family are enteropathogenic Escherichia
coli (EPEC) (27) and enterohemorrhagic E. coli (EHEC) (13).
EPEC and EHEC strains are important causative agents of
diarrheal diseases in humans worldwide. EPEC is responsible
for infantile diarrhea predominantly in developing countries
(28), whereas EHEC causes hemorrhagic colitis which can be
complicated by systemic manifestations, such as hemolytic-
uremic syndrome (35). Genes encoding the A/E phenotype are
located on a large (35-kb) chromosomal pathogenicity island
termed the locus of enterocyte effacement (LEE), which has
been associated with the ability to induce diarrheal disease (12,
26, 30). This pathogenicity island contains approximately 41
genes organized into several polycistronic operons (10). Ap-
proximately half of the genes located in the LEE encode a type
III secretion system that transfers proteins to host cells.
Among these genes are those that code for the translocation
proteins EspA (19), EspB (30), and EspD (22), which are
critical in the pathogenesis of infection in vitro and in vivo.
Two additional proteins which are encoded by the LEE and
are essential for colonization and induction of an immune
response are the outer membrane adhesion molecule intimin
and its cognate receptor Tir (translocated intimin receptor).
Intimin (15) and Tir (11) in particular appear to be of critical
importance for the development of TMCH. Previously, it has
been shown that transformation of the LEE pathogenicity is-
land alone into laboratory strains is sufficient to trigger the
characteristic A/E lesions in vitro (26).
Beside the LEE pathogenicity island, additional genes out-
side this well-defined chromosomal region contribute to the
pathophysiology of enteric gram-negative infection. Previously,
we and others have identified an inhibitory protein named
lymphostatin (21) in bacterial lysates from A/E pathogens.
Lymphostatin is encoded by a large chromosomal gene, termed
lifA for lymphocyte inhibitory factor A, in EPEC strain E2348/
69. Lymphostatin induces a profound suppression of lympho-
cyte activation in vitro. Lymphocyte cultures from different
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species preincubated with lymphostatin are unable to produce
significant amounts of interleukin 2 (IL-2), IL-4, and gamma
interferon protein and do not proliferate in response to mito-
gen stimulation (20). Interestingly, lifA has also been identified
to function as an adhesion factor for EHEC E45035N (31) and
EPEC JPN 15 (39) and has therefore been termed efa1 (EHEC
factor for adherence). Studies performed in vitro revealed that
mutation of E45035N lifA/efa1 significantly decreased bacterial
adherence to cultured epithelial cells.
Cross hybridization experiments and assays for inhibitory
activity have identified lifA/efa1-similar genes in other gram-
negative bacteria that demonstrate the A/E phenotype, includ-
ing rabbit enteropathogenic E. coli 1 (RDEC-1) (44) and
mouse pathogen C. rodentium (unpublished data). As the study
of A/E pathogens in humans is difficult, infection of mice with
C. rodentium has been used as a surrogate model for human
infection with EHEC and EPEC.
Additional genes located outside the LEE pathogenicity is-
land have been identified as critical virulence factors in C.
rodentium pathogenesis. NleA (non-LEE-encoded effector A)
(14) is translocated by the TTSS, targeting the Golgi apparatus
for an effect that is currently unclear. Our study was conducted
to further clarify the role of lifA/efa1, which is not part of the
LEE, and its gene product lymphostatin/Efa1 in the pathogen-
esis of TMCH in mice in vivo. In comparison to animals in-
fected with the wild type, mice infected with mutant lifA/efa1
strains did not display systemic signs of infection. Infection
with a nonmotif mutated strain did not result in significant
differences in colonic colonization until day 8. However, dele-
tion-insertion mutation of two critical motifs in lifA/efa1 re-
sulted in significantly decreased colonic colonization during all
time points of the investigation. TMCH did not develop in any
of the animals infected with the lifA/efa1 mutant strains at any
time. This report characterizes an additional bacterial gene
located outside the LEE pathogenicity island and its critical
role in colonic colonization and the pathogenesis of TMCH.
MATERIALS AND METHODS
Bacterial strains, growth conditions, and lysis. The bacterial strains used in
this study are listed in Table 1.
To generate bacterial lysates, bacteria were grown overnight in Luria-Bertani
broth supplemented with nalidixic acid (50 g/ml) for EPEC strain E2348/69 and
with ampicillin (25 g/ml) for the C. rodentium wild type, EID3, and EI3B8.
Bacterial cultures were centrifuged at 4,000  g, washed in phosphate-buffered
saline (PBS) once, and lysed by French press at 20,000 lb/in2. Bacterial cell debris
was removed by centrifugation at 1,000  g, and protein concentration was
determined by the bicinchoninic acid method (Pierce, Rockford, Ill.).
C. rodentium genetic techniques. Bacterial genomic DNA from C. rodentium
was partially digested with Sau3AI to yield fragments ranging in size from 20 to
40 kbp and ligated at fivefold molar excess into pHC79 DNA linearized with
BamHI. Ligated DNA was packaged by using a commercially available kit (Gi-
gapack II XL; Stratagene, La Jolla, Calif.) and transfected into E. coli DH5
grown in LB broth-2% maltose. Transfectants were plated on LB agar supple-
mented with 50 g of ampicillin/ml. Individual clones were stored in LB broth-
ampicillin (50 g/ml)-15% glycerol in 96-well plates at 70°C. Screening of the
genomic C. rodentium library was performed by colony blot hybridization by
using a radioactively labeled internal 1.79-kb EcoRI lifA/efa1 fragment from
EPEC E2348/69. Hybridization with an internal lifA/efa1 EcoRI fragment from
EPEC E2348/69 and subsequent restriction digest analysis with EcoRI identified
p3-B-8 as the clone with the smallest genomic fragment insertion (approximately
20 kb in size) (data not shown) and expression of inhibitory activity when
incubated with activated lymphocyte cultures. p3-B-8 was subjected to commer-
cial shotgun analysis covering the DNA sequence 8 to 10 times with the BigDye
Terminator method and the capillary 3700 system (Medigenomix, Martinsried,
Germany).
To generate in-frame mutations in the lifA/efa1 gene, we applied a method
described previously (7). An overnight culture of wild-type C. rodentium was
diluted 1:50 in salt-optimized broth and grown to an optical density at 600 nm
(OD600) of 0.6. Bacteria were made electrocompetent and concentrated 200-fold
in 10% glycerol-H2O, and 35 l was used for transformation with approximately
1 g of pKD46. Following electroporation (Bio-Rad, Hercules, Calif.) at 2.5 kV,
transformed bacteria were recovered in 1 ml of salt-optimized broth with carbon
at 30°C for 60 min without antibiotics. Serial dilutions (104 to 107) were plated
on LB agar plates containing 200 g of ampicillin (Sigma Chemical Co., St.
Louis, Mo.)/ml and incubated overnight at 30°C. Successful transformation of
individual clones was confirmed by adding 3 l of bacterial culture directly to 45
l of PCR Supermix HiFi (Invitrogen, Carlsbad, Calif.) and 1 l of each 20 M
pKD46-specific primer pair for genes encoding Gam (Klapp-110–Klapp-111) and
exonuclease protein (Klapp-112–Klapp-113) (Table 2). Reactions were carried
out in a Mastercycler (Eppendorf, Hamburg, Germany) with the following pro-
gram: 94°C for 4 min. followed by 30 cycles of 94°C for 1 min, 53°C for 1 min, and
68°C for 2 min. PCR samples were electrophoresed on a 2% agarose gel, stained
in 1% ethidium bromide, and examined under UV light. A single clone contain-
ing pKD46 (CrpKD46) was grown in 100 ml of SOB and 10 mM arabinose to an
OD600 of 0.6, made electrocompetent as outlined above, and stored at 80°C
until further use.
In parallel, six C. rodentium lifA/efa1-specific primers consisting of 74 to 80
nucleotides each were designed: 54 to 60 nucleotides with C. rodentium lifA/efa1-
specific sequences and an additional 20 nucleotides recognizing sequences up-
stream and downstream of the kanamycin resistance cassette in pKD4 (Table 2).
Primer pairs were designed not to disrupt the open reading frame (ORF) fol-
lowing recombination with helper plasmid pFT-A (see below). PCR amplifica-
tion was performed for each primer pair in eight independent reactions consist-
ing of 45 l of PCR Supermix HiFi (Invitrogen), 10 ng of pKD4 template, and
1 l of a 20 M concentration of each primer combination (Klapp-165–Klapp-
167, Klapp-102–Klapp-103, and Klapp-169–Klapp-170) (Table 2), utilizing the
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Description Source or reference
EPEC E2348/69 O126:H6 isolate from infant diarrhea 22a
C. rodentium Wild type causing and TMCH and colitis ATCC
pKD46 Red recombinase system 7
pKD4 PCR template for Km cassette and FRT 7
pFT-A Helper plasmid encoding for recombinase 32a
p3-B-8 C. rodentium lifA/efal cosmid clone This study
CrpKD46 C. rodentium wild type transformed with pKD46 This study
EIB2K1 Kanamycin insertion mutation at bp position 3,496 This study
EID3 Kanamycin-cured lifA/efa1 non-motif mutant This study
EI3B8 EID3 complemented lifA/efa1 on plasmid p3-B-8 This study
G1M9 Kanamycin insertion mutation at bp position 1,672 This study
G1M12 Kanamycin-cured lifA/efa1 glycosyltransferase motif mutant This study
PrMC1 Kanamycin insertion mutation at bp position 3,456 This study
PrMC31 Kanamycin-cured lifA/efa1 protease motif mutant This study
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PCR program described above. Following amplification, PCRs were pooled,
precipitated with isopropanol, dissolved in water, and digested overnight with 10
U of DpnI (New England BioLabs Inc., Beverly, Mass.). Digested PCR frag-
ments were gel purified and dissolved in water, and concentrations were deter-
mined at OD260 and OD280.
Approximately 1 g of gel-purified PCR product was electroporated with 2.5
kV into CrpKD46, and transformants were recovered for 2 h in 1 ml of SOC with
10 mM arabinose at 37°C. A 100-l bacterial culture aliquot was spread on LB
agar plates containing 100 g of kanamycin and incubated at 42°C overnight.
Recombinant clones were replica patched on LB agar plates containing ampi-
cillin (200 g/ml) and kanamycin (100 g/ml). Mutant clones with a resistance
cassette insertion that grew on kanamycin-supplemented but not ampicillin-
supplemented plates were confirmed by PCR as described above. Verification of
insertion at positions 1,672, 3,496, and 4,303 bp was performed with 1 l of a 20
M concentration of each primer in combination (Klapp-187–Klapp-188, Klapp-
136–Klapp-137, and Klapp-201–Klapp-202, respectively) (Table 2), utilizing the
identical amplification program listed above. Confirmation by PCR led to the
identification of insertion mutants EIB2K1 (nonmotif mutant), GlM9 (glycosyl-
transferase motif mutant), and PrMC1 (protease motif mutant) (Table 1).
To cure the kanamycin resistance cassette from lifA/efa1, insertion mutant C.
rodentium strains EIB2K1, GlM9, and PrM1 were made electrocompetent and
transformed as described above, with 100 ng of pFT-A (32). Transformed bac-
teria were recovered in 1 ml of SOC, spread on LB agar plates with 200 g of
ampicillin/ml, and incubated overnight at 30°C. Recombination of ampicillin-
resistant C. rodentium containing pFT-A was induced with a 1/10 volume of 200
g of heat-inactivated chlortetracycline (Sigma)/ml for 6 h at 30°C. Serial dilu-
tions (104 to 106) of bacterial culture were spread on LB agar without anti-
biotics and recombinant clones were replica patched the following day on three
different LB agar plates containing either no antibiotics, ampicillin (200 g/ml),
or kanamycin (100 g/ml). Individual clones that grew on LB but not on ampi-
cillin- or kanamycin-containing plates were further analyzed by PCR with 1 l of
a 20 M concentration of each primer in combination (Klapp-187–Klapp-188,
Klapp-136–Klapp-137, and Klapp-201–Klapp-202) (Table 2) as outlined above.
PCR products from all three mutant strains were gel-purified, cloned into pCR-
TOPO2.1 (Invitrogen) according the manufacturer’s specifications, and analyzed
by sequencing with M13 forward and reverse primers in order to confirm the
presence of “scar” sequence and in-frame mutation.
To complement the lifA/efa1 mutation, EID3 was made electrocompetent and
transformed with 1 g of p3-B-8. Transformed EID3 was selected on LB agar
with ampicillin (200 g/ml) and confirmed by PCR with lifA/efa1-specific primer
pair Klapp-136–Klapp-137 and a primer combination for vector-specific se-
quences (Klapp-256–Klapp-257), utilizing the identical PCR protocol outlined
above.
PBMC stimulation and lymphokine analysis by enzyme-linked immunosor-
bent assay (ELISA). Peripheral blood mononuclear cells (PBMC) were isolated
from peripheral blood from healthy volunteers. Whole blood was diluted 1:1 in
PBS, layered over Histopaque 1077 (Sigma), and centrifuged at 400  g for 20
min at 94°C. Mononuclear cells were aspirated, washed in PBS, and centrifuged
at 200  g for 10 min at 23°C. Cell pellets were resuspended in complete RPMI
1640 (Gibco BRL Inc, Grand Island, N.Y.) with 2 mM glutamine, 1 mM sodium
pyruvate, 20 mM HEPES buffer (pH 7.4), and 10% heat-inactivated fetal calf
serum (Sigma). PBMC were diluted to a concentration of 106/ml and incubated
at 37°C in a 5% CO2 atmosphere.
Analysis of lymphokine expression was performed by incubating 106 PBMC/ml
with increasing concentrations of bacterial lysates, ranging from 2.5 to 50 g/ml.
Following a 2-h preincubation, PBMC cultures were stimulated with a combina-
tion of pokeweed mitogen (10 g/ml) and phorbol myristate acetate (10 ng/ml)
as previously described (20). The cell supernatant was analyzed for IL-2 by
ELISA (Biosource International, Camarillo, Calif.) according the manufactur-
er’s specifications after a total of 24 h of incubation. Microtiter plates were read
at 450 and 650 nm, and the cytokine concentrations in the supernatant were
determined with a linear-linear standard curve. Mean values of raw cytokine
concentrations were normalized and expressed as percentages of the positive
control according the following formula: (S  N)/(P  N)  100% (S, cytokine
concentration; P, positive control; N, negative control). Mean values of duplicate
cytokine samples from three independent experiments were analyzed by Stu-
dent’s t test, and two-tailed P values of 0.05 were considered statistically
significant.
Immunofluorescence labeling and confocal microscopy. 3T3 cells were seeded
in eight-well chamber slides in Dulbecco’s modified Eagle medium (Gibco BRL)
and 10% fetal calf serum (Sigma) the day prior to the experiment. Bacterial
strains were grown overnight at 37°C without shaking in LB broth (Sigma)
supplemented with 50 g of nalidixic acid/ml (EPEC), 25 g of ampicillin/ml (C.
rodentium, EID3), and 100 g of ampicillin/ml (EI3B8). 3T3 cells were directly
infected with 10 l of EPEC and 50 l of each C. rodentium strain for 5 h. At 5 h,
fibroblasts were rinsed three times in Dulbecco’s PBS (DPBS) and fixed in 3.7%
paraformaldehyde in DPBS for 20 min. 3T3 cells were then rinsed twice with
DPBS and permeabilized with 0.2% Triton X-100 for 20 min and blocked with
1% bovine serum albumin in DPBS, pH 7.4, for 1 h. Filamentous actin was
labeled with 6.6 nM Alexa Fluor 488 Phalloidin (Molecular Probes, Eugene,
TABLE 2. PCR primer combinations for molecular methods
Primer name Sequencea Description
Klapp-110 5-ATGGATATTAATACTGAAACTGAG-3 Gam protein
Klapp-111 5-TTATACCTCTGAATCAATATCAAC-3 Gam protein
Klapp-112 5-ATGACACCGGACATTATCCTGCAG-3 Exonuclease
Klapp-113 5-TCATCGCCATTGCTCCCCAAATAC-3 Exonuclease
Klapp-102 5-ACAATAAATGGACTAGGGATAACAGGTGTACACACTGCAGAATGCCTGCT
ACCGGCACCAgtgtaggctggagctgcttc-3
bp 3,496–3,555, lifA/efa1-pKD4
Klapp-103 5-CAAATTGTCAAAACCATCAGCAGCACTGACCATCACCTGTTCTGTAATTTT
TCCGTTAATcatatgaatatcctccttag-3
bp 3,640–3,669, lifA/efa1-pKD4
Klapp-165 5-TACTGTATTATGAAGGGAGTTACAGATATTAATGATGAGTTACGAGTAAA
CTATgtgtaggctggagctgcttc-3
bp 1,297–1,350, lifA/efa1-pKD4
(glycosyltransferase motif)
Klapp-167 5-ACGTAGCTTTAAGTCTTCCAGGAAACGATTATCTCCATTTGTTTCCATCAT
AATcatatgaatatcctccttag-3
bp 1,672–1,725, lifA/efa1-pKD4
(glycosyltransferase motif)
Klapp-169 5-CATGCACAGGGATGGTTCGAAGTGGCCAAAGGATATGGCAGCCAGAATA
TTGACgtgtaggctggagctgcttc-3
bp 4,303–4,356, lifA/efa1-pKD4
(protease motif)
Klapp-170 5-TAATTGTATACCAGCCTCAATAAACTTCAGAGCATCCAGGGAAGAAAGGA
AATCcatatgaatatcctccttag-3
bp 4,441–4,494, lifA/efa1-pKD4
(protease motif)
Klapp-187 5-TACTGTATTATGAAGGGAGTTA-3 bp 1,297–1,318, lifA/efa1
Klapp-188 5-AAGCCCACGTATATTCCATCCG-3 bp 1,938–1,959, lifA/efa1
Klapp-136 5-AGCAGACGAGTTCAAGGGATA-3 bp 3,363–3,383, lifA/efa1
Klapp-137 5-CAAATTGTCAAAACCATCAGC-3 bp 3,649–3,669, lifA/efa1
Klapp-201 5-ATCGTTGAACACGCCAAATAT-3 bp 4,249–4,269, lifA/efa1
Klapp-202 5-TCTGGTCATCAGGGCATTATC-3 bp 4,528–4,548, lifA/efa1
Klapp-256 5-AATTCTCATGTTTGACAGCT-3 pHC79
Klapp-257 5-AATTCTCATGTTTGACAGCT-3 pHC79
a Uppercase letters, nucleotides with C. rodentium lifA/efa1-specific sequences; lowercase letters, nucleotides recognizing sequences upstream and downstream of the
kanamycin resistance cassette in pKD4.
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Oreg.). Nuclear counter staining was performed with 1 M TO-PRO-3 iodide
(642/661) for 10 min, followed by two rinses in DPBS. Stained monolayers were
examined with a Zeiss LSM510 laser scanning confocal microscope (Zeiss Mi-
croimaging, Thornwood, N.Y.) coupled to a Zeiss 100 M Axiovert.
Fibroblast adhesion assay. Prior to experiments determining the numbers of
adherent bacteria, we correlated the OD600 with CFU for EPEC and C. roden-
tium strains used in this study. The mean CFU per OD unit for EPEC was
determined at 2.39  107 and for C. rodentium strains at 1.48  107. A method
to quantify bacterial adherence has been described previously (25). Briefly, 3T3
cells were seeded into 96-well plates the day prior to infection with bacteria.
Following the removal of antibiotics by rinsing cells in PBS three times, cultures
were inoculated in triplicate with 5  106 CFU per strain and per well, centri-
fuged at 400  g for 15 min at room temperature, and incubated at 37°C and 5%
CO2 for a maximum of 4 h. Cells were washed three times with PBS for 4 h and
lysed with 1% Triton X-100–PBS for 5 min. Serial dilutions were spread on
MacConkey agar plates and counted the following day. Data from three inde-
pendent experiments were calculated as mean CFU with standard errors (SE)
per 105 3T3 cells and subjected to Student’s t test for statistical analysis.
Mouse strains and oral infection. Animal use and in vivo research complied
with all relevant institutional policies and federal guidelines. Female, 4- to
6-week-old, pathogen-free C57BL/6 mice were purchased from the Jackson
Laboratory (Bar Harbor, Maine). Animals were kept in cages, in groups of five
animals per cage, with unlimited access to water and food throughout the ex-
periment. Mice used in this study were weighed prior to infection to determine
mean baseline weights and every day thereafter. Weight was normalized, and
changes were expressed as percent changes in comparison to the baseline.
Bacterial strains were grown overnight in LB medium, centrifuged at 400  g,
and washed once in PBS. Following a second centrifugation step, bacterial
cultures were resuspended in PBS, and numbers of CFU were approximated by
measuring the OD600. Groups of five animals for each time point (days 2, 8, 14,
and 20) and the EPEC, C. rodentium wild type, EID3, EI3B8, GlM12, and PrM31
groups were orally infected with 100 l of PBS containing an approximately 3 
108 CFU bacterial solution per strain; control mice received PBS only. To
determine the exact infectious dose per animal, serial dilutions of the bacterial
solutions were plated on MacConkey II agar plates (Becton Dickinson and Co.,
Sparks, Md.), incubated at 37°C overnight, and enumerated the following day.
Tissue collection. Animals were euthanized on days 2, 8, 14, and 20 of the
infection by terminal anesthesia with isoflurane (Abbott Laboratories, North
Chicago, Ill.) followed by cervical dislocation. The distal colon from each animal
was excised from the anal verge to mid-colon and divided into two equal parts of
approximately 0.5 cm in length. The proximal section of the distal colon was fixed
in formalin solution for histological analysis, and the distal section was homog-
enized in 1 ml of PBS to determine colon colonization.
Bacterial colonization counts. Following removal of all fecal pellets, the distal
section of colon of approximately 0.5 cm in length from each animal was weighed
and homogenized in 1 ml of PBS at low speed with a Tissuemizer (Fisher
Scientific, Pittsburgh, Pa.). Serial dilutions of tissue homogenate in LB broth
were plated on MacConkey agar (Becton Dickinson) plates and enumerated the
following day. Only colonies that displayed the characteristic pink center sur-
rounded by a white rim (C. rodentium strains) or a purely pink appearance
(EPEC E2348/69) were counted. Colon colonization was calculated and ex-
pressed as CFU per gram of tissue with standard errors. Statistical analysis was
performed by utilizing the Mann-Whitney U test (P  0.05).
Transmission electron microscopy. Colonic tissue from control and infected
mice was fixed in 4% glutaraldehyde and cut into 1-m strips by using a mic-
rotome. The strips were postfixed in 1% osmium tetroxide, sequentially dehy-
drated through graded alcohols and propylene oxide, and then infiltrated with
Embed-812 (Electron Microscopy Sciences, Ft. Washington, Pa.). Strips were
embedded for cross-section orientation. Semithin (0.5-mm) sections were cut,
stained with toluidine blue, and examined for adequacy. Ultrathin (900-Å) sec-
tions were cut with a diamond knife, stained with uranyl acetate and lead citrate,
and examined with an EM201 electron microscope (Philips Electronics, Maha-
wah, N.J.).
Histology. Following removal of the distal colon from each animal used in this
study, the proximal section of distal colon was fixed in a 10% (vol/vol) formalin
solution for 2 days and processed for embedding in paraffin. Transverse sections
(5 m) were stained with hematoxylin and eosin. Histological analysis was per-
formed by two independent pathologists who were blinded to the experimental
conditions. Tissue sections from infected and uninfected mice in all groups were
analyzed on day 2, 8, 14, and 20 for epithelial regenerative changes and the
nature of the inflammatory cell infiltrate. Regenerative changes were identified
based on cytological changes of crypt epithelial cells and mucosal thickness. The
cytological criteria used were increased nuclear-to-cytoplasmic ratio, increased
mitotic activity, and diminished mucin production. Mucosa from control animals
was used to define baseline mucosal thickness. Alterations in thickness are
expressed as a percent increase from the baseline. Cytological changes were
graded as 1 (no changes), 2 (minimal, involving crypts with 20% increases
in mucosal thickness), 3 (mild, extending up to half of the crypt height with 20
to 80% increases in mucosal thickness), 4 (moderate, extending over half of the
crypt height with surface maturation and with 80 to 100% increases in mucosal
thickness), and 5 (florid, involving the entire crypt and surface epithelium with
100% increases in mucosal thickness). Scores determined for epithelial regen-
erative changes were analyzed by Student’s t test (P  0.05).
Statistical analysis. Nonparametric analysis of organ colonization counts was
performed by Mann-Whitney U test. Data from IL-2 suppression, bacterial
fibroblast adhesion, weight changes, and epithelial regenerative changes were
subjected to Student’s t test. Differences were considered significant if P was
0.05.
Nucleotide sequence accession number. The nucleotide sequence of C. roden-
tium lifA/efa1 is available at GenBank under accession number AY726731.
RESULTS
Identification and sequence analysis of lifA/efa1 of C. roden-
tium. The cosmid clone p3-B-8 generated from C. rodentium
serotype 4280 contained a single large ORF (Fig. 1) that was
9,627 bp in size and encoded a protein with a calculated size of
363,588 Da. The G/C content of this ORF was 42%, which is
lower than that of the genomic DNA from K-12 E. coli. A
protein-protein BLAST search including the entire length of
translated C. rodentium lifA/efa1 sequence identified significant
similarities for lifA/efa1 from EPEC E2348/69 (85%, 9,669 bp,
365,968 Da), which was slightly larger in size. Additional sim-
ilarities were identified for lifA/efa1 from EHEC strains
O157:H (85%), O157:H7 (68%), and RIMD 0509952, as well
as for genes present in two obligate intracellular pathogens,
Chlamydophila caviae (Chlamydia psittaci) (33) and Chlamydia
muridarum. Interestingly, C. muridarum harbors two tandem
lifA/efa1 homologous sequences separated by only 21 bp. Anal-
ogous to lifA/efa1 in EPEC, C. rodentium lifA/efa1 encodes
three distinct motifs: glycosyltransferase motif at amino acid
positions 553 to 555, a protease motif with three critical resi-
dues at 1,466, 1,568, and 1,584, and an aminotransferase II
motif from amino acids 1,932 to 1,941.
Limiting the sequence analysis to approximately 500 amino
acids flanking the glycosyltransferase motif, additional signifi-
cant similarities were identified, as previously reported, for the
FIG. 1. The C. rodentium lifA/efa1 gene. The lifA/efa1 gene from C.
rodentium was identified on cosmid clone p3-B-8 by testing bacterial
lysates in an inhibitory assay and cross hybridization with an internal
EcoRI fragment from EPEC strain E2348/69 lifA/efa1. The D-X-D
motif in C. rodentium lifA/efa1, encoding a glycosyltransferase activity
and inactivating small GTP-binding proteins, is also present in large
clostridial cytotoxins. The protease motif is present in avirulence pro-
teins of plant pathogens and YopT, and it disrupts the actin cytoskel-
eton in host cells. The third distinct motif present in C. rodentium
lifA/efa1 encodes an aminotransferase II. Areas in grey indicate do-
mains with significant sequence similarities to known motifs present in
other gram-negative bacteria. Three domains of the lifA/efa1 gene in C.
rodentium were mutated, generating mutant GlM12, PrMC31, and
EID3 (arrows).
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N-terminal residues of large clostridial cytotoxins. These in-
clude  toxin from Clostridium novyi (4), toxins A and B from
Clostridium difficile (18), and lethal toxin from Clostridium sor-
dellii (3, 17). Relevant sequence similarities coding for a gly-
cosyltransferase motif were also identified for Chlamydia tra-
chomatis and various Plasmodium spp., including P. falciparum,
P. vivax, and P. yoeleii. The second distinct motif in C. roden-
tium lifA/efa1 is located at residues 1,466, 1,568, and 1,584 and
encodes a cysteine protease motif. This protease motif consists
of three conserved amino acids that have been shown to be of
equal importance for biological activity, including a cysteine,
histidine, and aspartic acid residue, respectively. The motif is
present in a number of other bacterial proteins and has been
well characterized for YopT (Yersinia outer membrane protein
T). YopT cleaves posttranslationally prenylated Rho GTPases
(38), resulting in disruption of the cellular actin cytoskeleton
(37). A third conserved region, from amino acids 1,932 to
1,941, codes for an aminotransferase II motif. It consists of 10
residues, TMGKALSASA, which are present in other pyri-
doxal phosphate-dependent enzymes, covalently binding pyri-
doxal phosphate to a lysine residue.
lifA/efa1 mutations in C. rodentium and complementation.
To characterize the role of lifA/efa1 in vivo, we generated three
insertion-deletion mutations at bp positions 1,350, 3,556, and
4,356 (Fig. 1). Mutations at 1,350 and 4,356 bp were chosen to
inactivate the glycosyltransferase and protease motif, deleting
amino acids 451 to 557 and 1,453 to 1,480, respectively. The
third location for a mutation at 3,556 bp was generated to
delete amino acids 1,186 to 1,256 of the protein, thereby leav-
ing known motifs intact. Activation of pKD46 in wild-type C.
rodentium resulted in recombination of linear PCR products
containing the kanamycin resistance cassette into wild-type
lifA/efa1, generating strains EIB2K1, GlM9, and PrMC1, in-
creasing the size of the lifA/efa1 gene by 1,477 bp. The kana-
mycin resistance cassette was cured by utilizing helper plasmid
pFT-A. As expected, deletion of the resistance cassette de-
creased lifA/efa1 by 129 bp in position 3,355 bp, by 237 bp in
position 1, and by 350 bp and no net loss in position 4,356 bp
(data not shown). To determine if the scar sequence, consisting
of a single FLP recognition site, was in frame with the remain-
der of the lifA/efa1 ORF, all mutated lifA/efa1 sequences were
cloned and sequenced in the 5 and 3 directions. Sequence
analysis confirmed that additional, accidentally introduced nu-
cleotides were absent and that the 84-bp scar sequence was in
frame with the lifA/efa1 ORF for all three mutants (data not
shown).
Plasmid p3-B-8 containing lifA/efa1 was used to complement
lifA/efa1 mutant C. rodentium strain EID3 (see above). Follow-
ing electroporation and selection, individual colonies were sub-
jected to PCR analysis, confirming the presence of vector and
wild-type lifA/efa1 sequences.
In vitro analysis of lysates from EPEC, C. rodentium, EID3,
and EI3B8 for IL-2 suppressive activity. Previously, we have
characterized lifA/efa1 to code for a lymphokine-inhibitory ac-
tivity leading to profound suppression of IL-2 expression in
vitro. Analogous to these experiments, we lysed wild-type
EPEC strain E2348/69 and C. rodentium, as well as mutant
clones EID3 and complemented strain EI3B8 by French press.
As expected, lysates from wild-type E2348/69 and C. rodentium
led to dose-dependent suppression of IL-2 protein expression
after 24 h of culture (Fig. 2A). In comparison to wild-type C.
rodentium and EI3B8, lysates from lifA/efa1 mutant strain
EID3 did not contain significant inhibitory activity at concen-
trations equal to or greater than 5 g/ml (Student’s t test, P 
0.05).
Fibroblast attaching and effacing assay in vitro. EPEC,
EHEC, and C. rodentium belong to a family of bacteria that
upon adhesion to epithelial cells induce the accumulation of
filamentous actin beneath the site of bacterial attachment and
loss of microvilli, termed A/E. We have shown previously that
a mutation in lifA/efa1 did not interfere with the ability of
EPEC strain E2348/69 to induce A/E lesions in Hep-2 cells in
vitro (21). However, this mutation was located in the C-termi-
nal portion of lifA/efa1, whereas for the present study we in-
troduced a mutation in the N-terminal half of lifA/efa1. We
therefore sought to determine the effect of an N-terminal mu-
tation on the ability of C. rodentium to induce attaching lesions
in 3T3 fibroblast cells.
Actin accumulated underneath the site of bacterial attach-
ment was observed for all four strains used in this study (Fig.
2B). Characteristically, EPEC formed clusters of microcolo-
nies, whereas Citrobacter strains displayed a more diffuse pat-
tern of adherence over the entire cell surface area. Comparing
EPEC and the C. rodentium wild type to EID3 and EI3B8, we
were unable to detect a difference in quality and quantity of
actin pedestal formation after 4 h of infection. Therefore,
mutation of lifA/efa1 did not interfere with the formation of
characteristic attaching lesions in 3T3 cells in vitro.
Quantification of bacterial adhesion to 3T3 cell cultures. To
quantify the number of cell-associated bacteria, we infected
3T3 cells with 5  106 CFU of EPEC, C. rodentium, EID3, or
EI3B8. As expected, the numbers of adherent bacteria in-
creased over time when measured at 4 h postinfection for all
four strains investigated. We did not observe a statistically
significant difference comparing the numbers of adherent bac-
teria to 3T3 cells at 4 h after infection with C. rodentium wild
type, EID3, and EI3B8 strains (Fig. 2C), as determined by
Student’s t test. Therefore, bacterial adherence to 3T3 fibro-
blasts was independent of lifA/efa1 in vitro.
Weight loss during C. rodentium infection. To determine the
systemic effect of lifA/efa1 in vivo, we infected female 4- to
6-week-old C57BL/6 mice by gavage with EPEC, the C. roden-
tium wild type, lifA/efa1 mutant EID3, and complemented mu-
tant EI3B8. EPEC functioned as a negative control, as it poorly
colonizes mouse intestine and induces only minimal patholog-
ical changes. Animals were weighed prior to infection and
every day thereafter throughout the 20-day experiment. Body
weights were expressed as percent changes in comparison to
the baseline at day 0 (Fig. 3).
In contrast to mice infected with wild-type C. rodentium,
animals inoculated with mutant lifA/efa1 strain EID3 steadily
gained weight throughout the experiment. Growth curve shape
and overall increase in mean body weight of the EID3 group
were identical to those of EPEC-infected and uninfected con-
trol mice. These mice steadily gained weight to 110% of base-
line by day 20. Stool samples examined from these animals
were never loose, nor did these animals exhibit decreased
activity or perianal fecal staining. As expected, all mice in-
fected with wild-type C. rodentium started to lose weight by day
5, and this weight loss continued until day 13 of the infection,
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after which the animals started to recover rapidly. Mice in-
fected with C. rodentium lost, on average, 13% of their body
weight by day 13. This group of animals displayed reduced
activity, perianal fecal staining, and loose fecal pellets. We
observed statistically significant differences (Student’s t test, P
 0.05) in weight between days 10 to 16 comparing wild-type
C. rodentium-infected mice with controls or animals that re-
ceived mutant strain EID3. Interestingly, groups of animals
that received the complemented strain EI3B8 failed to gain
weight throughout the experiment and did not exhibit the
characteristic decrease in body weight observed for wild-type
infected animals. In fact, by day 20, these animals had lost
approximately 3% of their baseline weight. In a comparison of
complemented mutant strain EI3B8 to lifA/efa1 mutant EID3,
EPEC, and uninfected controls, a significant difference in
weight was observed between days 13 and day 20 of infection
(Student’s t test, P  0.05). Therefore, lifA/efa1 mediates sys-
temic manifestations of infection with C. rodentium.
Transmission electron microscopy of colonic tissue sections.
To verify that the C. rodentium strains used in this study formed
A/E lesions in vivo, tissue from mice sacrificed on day 8 was
subjected to transmission electron microscopy. As shown in Fig. 4,
the C. rodentium wild type, EID3, and EI3B8 formed the char-
acteristic A/E lesions in vivo in infected mice. However, we were
unable to detect A/E lesions in vivo in mice infected with EPEC
strain E2348/69, which is consistent with the observation that
EPEC usually does not induce disease in laboratory animals.
Therefore, mutation of lifA/efa1 in C. rodentium does not inter-
fere with the formation of A/E lesions in vivo.
Colon colonization with EPEC, C. rodentium, EID3, and
EI3B8. Previous in vivo and in vitro experiments revealed that
lifA/efa1 plays a role in bacterial colonization. Cattle infected
with lifA/efa1 mutant Shiga toxin-producing E. coli (STEC)
strains displayed a decrease in fecal shedding in comparison to
wild-type infection (39). We therefore sought to determine if
the observed changes in body weight were due to a decreased
ability of lifA/efa1 mutant C. rodentium to colonize the colon of
infected mice.
FIG. 2. (A) Bacterial lysates from lifA/efa1 mutant strain EID3 lose
IL-2 inhibitory activity. PBMC (106/ml) were preincubated for 2 h with
increasing concentrations (ranging from 2.5 to 50 g/ml) of bacterial
lysates from EPEC (), C. rodentium wild type (■), lifA/efa1 mutant
strain EID3 (Œ), and complemented mutant EI3B8 (F). Lymphocyte
cultures were activated with the combination of pokeweed mitogen (10
g/ml) and phorbol myristate acetate (10 ng/ml). After a total of 24 h
of incubation, supernatants were aspirated and analyzed in duplicate
by ELISA. Data from three independent experiments were pooled,
and mean values with SE normalized against values for the positive
control were set at 100%. Unlike lysates from generated from EPEC,
C. rodentium, and EI3B8, lysates from lifA/efa1 mutant EID3 failed to
inhibit expression of IL-2 protein in activated lymphocyte cultures.
This difference was statistically significant (P 	 0.05) at concentrations
of 5 g/ml and greater for C. rodentium EI3B8 than for lysates from
EID3. Statistical differences were determined by Student’s t test and
considered significant if P was  0.05. (B) Formation of attaching
lesions in 3T3 cells in response to infection with EPEC, C. rodentium
(CrWT), EID3, and EI3B8. 3T3 cell cultures were infected with EPEC,
C. rodentium, EID3, and EI3B8 for 5 h, rinsed in PBS, fixed in para-
formaldehyde, and stained for nucleic acids and filamentous actin.
Images were obtained with a Zeiss Axiscope and digital imaging pack-
age. The accumulation of filamentous actin underneath the site of
bacterial adherence was not affected by a mutation in lifA/efa1, as
mutant and wild-type bacteria induced similar attaching lesions in 3T3
fibroblast cultures. (C) Quantification of bacterial adherence to fibro-
blast cultures. 3T3 cells were infected with 5  104 CFU of wild-type
EPEC and C. rodentium (CrWT), lifA/efa1 mutant EID3, and comple-
mented strain EI3B8. Infection was allowed to proceed for 4 h, when
cell cultures were washed three times with PBS and lysed in 1% Triton
X-100. Serial dilutions were plated on MacConkey agar plates, incu-
bated overnight, and enumerated the following morning. Bacterial
adherence to fibroblast cells was determined in triplicate in three
independent experiments. Data are expressed as means, with error
bars representing SE of the means, and were subjected to Student’s t
test for statistical analysis (P  0.05). Regardless of the presence or
absence of an intact lifA/efa1 gene, wild-type and mutant C. rodentium
adhered with equal efficiency to fibroblast cultures at 4 h of infection.
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Colony counts comparing EPEC, C. rodentium, EID3, and
EI3B8 on day 2 of the experiment did not reveal significant
differences (Fig. 5A). By day 8, colonization with C. rodentium
wild type, EID3, and EI3B8 had increased by approximately 3
log CFU/g of tissue. However, we did detect a significant dif-
ference in colonization of approximately 1 log fold comparing
wild-type C. rodentium to EID3 (P 
 0.032) on day 8. The C.
rodentium wild type and EI3B8 were able to maintain a high
colonization count in the distal colon on day 14, but EID3
displayed a 4-log-fold reduction in CFU/gram of tissue, counts
comparable to those for EPEC. By day 20 of the infection,
colonization numbers were comparable for all four strains,
without significant differences. Throughout the 20-day experi-
ment, wild-type C. rodentium and EI3B8 were indistinguish-
able in their ability to colonize the colon and we did not
identify significant differences at any of the four time points
investigated. This result was surprising, as we were unable to
detect p3-B-8 or lifA/efa1 wild-type-specific sequences by PCR
in individual bacterial colonies or whole colon homogenates
beyond day 2 of infection with EI3B8, indicating that the plas-
mid was not stable in vivo. As expected, EPEC was rapidly
cleared from the colon of infected animals, with the highest
bacterial counts occurring on day 2 and persistently low CFU
thereafter. Interestingly, mice infected with wild-type C. roden-
tium had significant higher colonization counts in other organs
investigated, including mesenteric lymph nodes, liver, small
bowel, and spleen (data not shown).
lifA/efa1 encodes a glycosyltransferase and protease motif
which have been implicated in the pathogenesis of bacterial
infection. In a separate experiment, our goal was to define the
role of these two critical motifs in colonic colonization. Time
course and infectious dose were identical, as described for Fig.
5A. In this second colonization experiment, wild-type C. ro-
dentium was able to maintain high colonization counts beyond
day 14, as CFU/gram of tissue were still elevated on day 20
(Fig. 5B). Remarkably, GlM12 and PrM31 were significantly
less able to colonize the distal colon than wild-type C. roden-
tium throughout the 20-day experiment. Despite an increase in
colony counts for GlM12 and PrMC31, this difference was
approximately 1 log fold on days 2 and 8 and increased 2 and
3 log fold by days 14 and 20, respectively.
We conclude that during the initial phase of infection, mu-
FIG. 3. Weight chart for mice infected with EPEC and C. rodentium strains. Enteric infection of groups of five mice with EPEC (), C.
rodentium (■), EID3 (Œ), and EI3B8 (F) was initiated by gavage with 3  108 CFU/animal in 100 l of PBS on day 0. Animals were weighed daily
until day 20 of infection, and data are expressed as means with error bars for SE. Statistical analysis was performed by Student’s t test, and results
were considered significant if P was 0.05. In comparison to mice infected with wild-type C. rodentium, EID3 did not induce signs and symptoms
of systemic disease, and animals gained weight throughout the 20-day experiment. Weight gain for control mice (E) and animals infected with EID3
and EPEC was indistinguishable.
FIG. 4. Transmission electron microscopy of EPEC, C. rodentium wild type, EID3, and EI3B8 on day 8 of infection. Morphology of colonic
tissue from infected mice at day 8 of infection was evaluated by transmission electron microscopy. Epithelial pedestal-like structures consistent with
A/E lesions were observed in the apical pole of epithelial cells infected with C. rodentium wild type (CrWT), EID3, and EI3B8.
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tant EID3 was able to colonize the colon of infected mice as
efficiently as wild-type bacteria. However, in comparison to
wild-type C. rodentium and EI3B8, EID3 had an accelerated
course of clearance from the colon between day 8 and day 14.
In addition, the glycosyltransferase and protease motifs of lifA/
efa1 are both equally important for sustained colonic coloni-
zation in infected mice.
Epithelial regenerative changes in response to infection with
EPEC, C. rodentium, EID3, and EI3B8. We next analyzed ep-
ithelial regenerative changes from the distal colon of infected
animals on day 2, 8, 14, and 20 following inoculation. To
quantify regenerative changes observed during the 3-week ex-
periments, two pathologists examined tissue sections from con-
trol and experimental mice in a blinded fashion. Epithelial
regenerative changes were scored ranging from mild (1) to
florid (5).
In comparison to uninfected mice, mice infected with wild-
type EPEC, wild-type C. rodentium, EID3, and EI3B8 all ex-
hibited an increase in epithelial regenerative changes during
the course of infection (Fig. 6A). Regenerative changes were
observed as early as day 2 in mice infected with EID3. In the
same group, markedly increased regenerative scores were re-
corded for days 8 and 14 and sustained through day 20. There
was no significant difference between groups of infected ani-
mals on day 8 or 14. However, a significant increase in epithe-
lial cell regeneration was observed on day 20 for animals in-
fected with wild-type C. rodentium, the infection being
significantly less severe in mice inoculated with EID3 (Fig.
6A). Based on these observations, it appears that lymphostatin/
Efa1 is an additional bacterial factor that contributes to epi-
thelial regeneration in mice infected with C. rodentium.
Histological changes in response to infection with C. roden-
tium occur as early as 2 days after infection and are fully
developed between days 14 and 20. On days 8, 14, and 20, distal
colonic sections from mice infected with EPEC, C. rodentium,
EID3, and EI3B8 were embedded in paraffin and stained with
hematoxylin and eosin (Fig. 6B). All infected mice displayed in
increase in mucosal thickness, which was in part due to epi-
thelial cell regeneration. Regeneration was still prominent on
day 14 and maintained until day 20. As described previously,
marked histological changes with inflammation and crypt cell
proliferation were apparent in mice infected with wild-type C.
rodentium by day 8 and continued to progress until the end of
the experiment on day 20. Interestingly, mild crypt cell prolif-
eration was also present in the EID3 group, peaking on day 14.
By day 20, pathological changes had completely normalized in
mice infected with EPEC and EID3. Mucosal thickness dou-
bled in C. rodentium wild-type-infected mice in comparison to
control and EPEC-infected animals. Interestingly, a mixed in-
flammatory infiltrate consisting of lymphocytes and neutro-
phils was observed only with infection with C. rodentium wild
type on days 14 and 20 and with infection with EI3B8 on day
14.
DISCUSSION
Enteric bacteria face an array of host defense mechanisms
that prevent their colonization, multiplication, and invasion.
Beside intestinal motility and fluid secretion, the innate and
adaptive mucosal immune responses are of critical importance
for containment and clearance of infection. However, enteric
pathogens have developed strategies that manipulate and
counteract immune activation to promote survival of their own
species.
FIG. 5. Bacterial counts of EPEC, C. rodentium, EID3, and EI3B8
isolated from the colon of infected mice. Following inoculation with
EPEC (), C. rodentium (■), EID3 (Œ), and EI3B8 (F) (A), wild-type
C. rodentium (■), GlM12 (‚), and PrM31 (E) (B) on day 0, animals
were sacrificed on day 2, 8, 14, or 20. Fecal pellets were removed from
the distal colon of infected animals, and tissue was weighed and ho-
mogenized at low speed. Serial dilutions were plated on MacConkey
agar, and recovered bacteria were counted the following day. Data
depict the mean CFU per gram of colon tissue of infected animals,
with bars representing the SE of the mean. Nonparametric analysis of
organ colonization counts was performed by the Mann-Whitney U test.
(A) Wild-type C. rodentium (■) and mutant EID3 (Œ) were able to
colonize the colon of infected animals with equal efficiency until day 8,
after which EID3 was rapidly cleared from the colon, decreasing to
levels similar to the CFU determined for EPEC (). (B) Mutations in
the glycosyltransferase (‚) and protease motif (E) resulted in signifi-
cantly reduced colonic colonization throughout the infection in com-
parison to wild-type C. rodentium infection (■).
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In the present study, we have begun to characterize the
function of lifA/efa1 from C. rodentium in vivo and its role in
colonic colonization, the development of colitis, and crypt cell
proliferation.
Lymphostatin/Efa1 has been characterized as an adhesion
factor for gram-negative bacteria, including EPEC JPN15 (1)
and EHEC strains E45035N (31) and O157:H7 (42). Muta-
tions of lifA/efa1 in E45035N, O157:H7, and JPN15 or pre-
treatment with polyclonal antibodies against lymphostatin/
Efa1 lead to markedly deficient adherence to epithelial cells
when tested in vitro. In addition, inactivation of lifA/efa1 in
STEC serotypes O5 and O111 resulted in a reduced associa-
tion with cultured HeLa cells (39). In the same study, inocu-
lation of 4- to 11-day-old calves with mutant STEC led to
significantly reduced numbers of shed bacteria in the feces,
which is currently the only available in vivo data regarding
lymphostatin/Efa1. In addition, there is support for a regula-
tory function of lifA/efa1 in bacterial adherence as lymphosta-
tin/Efa1 appears to regulate certain bacterial factors that are
important for adhesion (42). These factors include espA, espB,
and intimin, which were significantly decreased in bacterial
lysates from lifA/efa1 mutant O157:H7.
In contrast, our previous and present findings (Fig. 2 and 4)
suggest that mutant and wild-type lifA/efa1 strains display dif-
ferences in colonization but are equally efficient in adhering to
epithelial cells by establishing attaching lesions in vitro and in
vivo. This difference might be explained by the fact that certain
gram-negative bacteria rely on additional factors that mediate
adhesion to receptors on the cell surface. Unlike EHEC
strains, EPEC E2348/69 and C. rodentium harbor a mechanism
that potentially mediates bacterial adherence to epithelial
cells, the type IV pilus. In EPEC strains, the bundle-forming
type IV pilus is found on a 50- to 70-MDa plasmid (40),
whereas in C. rodentium the pilus-encoding sequence is located
on the bacterial chromosome (29). Signature-tagged mutagen-
esis of C. rodentium identified a novel type IV pilus gene
cluster that is required for colonization in vivo with similarity
to genes from enterotoxigenic E. coli and Vibrio cholerae. How-
ever, in contrast to results of experiments performed with
cattle, we did not find a role for lymphostatin/Efa1 as an
adhesion molecule in infected rodents. In the study by Mundy
et al., a mutation 736 bp downstream from C. rodentium lifA/
efa1, but not lifA/efa1 itself, resulted in an insignificant effect
on bacterial virulence in vivo with normal colonization be-
tween days 2 and 5. It is interesting that in the nonmotif mutant
EID3, a significant difference in colonization in comparison to
wild-type C. rodentium was not observed until day 8 of infec-
tion (Fig. 5A). These in vivo findings in mice are consistent
with our observations that lifA/efa1 is not a primary adhesion
molecule. First, we did not measure a statistically significant
FIG. 6. Time course of epithelial cell regenerative and histological
changes in response to infection with EPEC, C. rodentium, EID3, and
EI3B8. (A) Epithelial regenerative changes for all animals per group
were analyzed by two pathologists in a blinded manner on days 2, 8, 14,
and 20. The analysis included control animals and mice infected with
EPEC, C. rodentium (CrWT), EID3, and EI3B8. Cytological changes
were graded as 1 (no changes), 2 (minimal, involving crypts with
20% increases in mucosal thickness), 3 (mild, extending up to half
crypt height with 20 to 80% increases in mucosal thickness), 4 (mod-
erate, extending over half of crypt height with surface maturation and
with 80 to 100% increases in mucosal thickness), and 5 (florid,
involving entire crypt and surface epithelium with 100% increases in
mucosal thickness). Scores determined for epithelial regenerative
changes were analyzed by Student’s t test (P  0.05). Interestingly, all
infected animals responded with increased regenerative scores on days
2, 8, 14, and 20 of infection. A statistically significant difference in
regeneration was determined on day 20 of infection in a comparison of
scores obtained for EID3 and C. rodentium wild type. (B) Distal co-
lonic sections from each animal were fixed in formalin and embedded
in paraffin, and transverse 5-m sections were stained with hematox-
ylin and eosin. In comparison to control mice inoculated with PBS, all
groups responded with increased regenerative scores. TMCH devel-
oped only in wild-type C. rodentium (Cr WT)-infected mice by day 8
and increased in severity by day 20.
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difference in adherence to 3T3 fibroblast cultures in vitro com-
paring wild-type and mutant lifA/efa1 C. rodentium strains.
Second, a mutation in lifA/efa1 did not affect colonization of
EID3 until day 8 of infection. The third argument against
lymphostatin/Efa1 as a primary adhesion molecule is the fact
that the C. rodentium wild type, EID3, and complemented
mutant EI3B8 all induced A/E lesions on day 8 of infection.
Fourth, colonization counts for wild-type C. rodentium and
EI3B8 were indistinguishable at every time point during the
entire course of infection, despite the fact that we were unable
to detect lifA/efa1 wild-type gene- or vector-specific sequences
by PCR beyond day 2 of the infection with EI3B8. This phe-
nomenon is not unexpected, as wild-type bacteria poorly retain
cloned DNA and lose plasmids if selective pressure is not
maintained with antibiotics. However, these findings allow for
the argument that additional early events other than bacterial
adhesion play a significant role in successful colonization of C.
rodentium. It is currently unclear which early events are in-
volved, but we speculate that besides exhibiting an effect on the
adaptive immune response, lifA/efa1 might be involved in mod-
ulation of the innate immunity.
Components of the innate immunity encompass phagocytes,
epithelial cells, NK cells, and the complement system. It is
conceivable that lifA/efa1 exhibits a positive or inhibitory effect
on innate immunity by regulating cytokine expression and
phagocytosis, as has been described for EPEC. EPEC induces
IL-8 expression in epithelial cell cultures by activating the
mitogen-activated protein kinase pathway (6) and prevents its
own phagocytosis by inhibition of phosphatidylinositol 3-ki-
nase-dependent pathways (5). It is also possible that lifA/efa1-
induced modulation of the innate immunity results in a de-
creased adaptive immune response, allowing for high
colonization counts in C. rodentium wild-type-infected mice on
day 8 and 14. Possible linking mediators involved include cat-
ionic peptides, such as LL-37 (8) or defensins (41, 43), which
function as immune adjuvants and are found in abundance in
inflamed tissue. In this context, it is tempting to speculate that
a lifA/efa1-induced breakdown in the enteric immune system
and epithelial barrier function accounts for the systemic man-
ifestations in C. rodentium wild-type-infected animals, as de-
termined by changes in weight. In contrast to results with
wild-type-infected mice, EID3 was found to poorly colonize
organ cultures obtained from mesenteric lymph nodes, liver, or
spleen, despite similar colon colonization counts on days 2 and
8 for wild-type and lifA/efa1-mutant C. rodentium strains.
Regardless of the enteric pathogen used in this study, all
animals developed markedly increased epithelial cell regener-
ative scores during the 3-week infection. Unexpectedly, loss of
goblet cells and massive crypt cell proliferation were observed
only in mice infected with wild-type C. rodentium. It appears
that lymphostatin/Efa1 elicits a direct or indirect effect on
undifferentiated epithelial cells located on the bottom of co-
lonic crypts. The mechanism by which lymphostatin/Efa1 me-
diates this effect is currently unclear, with three possible ex-
planations for the phenomenon. First, infection with C.
rodentium has been shown to induce a fourfold increase in total
cellular -catenin protein concentrations by day 12 in vivo (36).
An increase in cellular -catenin was accompanied by an in-
crease in nuclear -catenin concentrations, and elevated levels
preceded crypt length elongation by about 2 days. The same
study revealed that cellular concentrations of cyclin D1 and
c-Myc, two proteins maintaining proliferation status, were in-
creased. Without significant differences in bacterial adhesion
in vitro and in vivo between results with wild-type and lifA/
efa1-mutant C. rodentium, it is attractive to speculate that lym-
phostatin/Efa1 has a direct or indirect effect on epithelial cell
proliferation mediated through the nuclear translocation of
-catenin. Second, the possibility of an indirectly mediated
increase in cell proliferation in response to lymphostatin/Efa1
might exist through an effect on a host factor, such as early
growth response factor-1 (EGR-1). In vitro and in vivo exper-
iments performed with C. rodentium lead to an increased tran-
scription of EGR-1 with subsequent activation of the MEK/
extracellular signal-regulated kinases (9), a signal transduction
pathway critical for cell proliferation (23). This effect was de-
pendent on an intact type III secretion mechanism, which was
necessary for the full induction of EGR-1 expression. A third
explanation is the fact that infection with C. rodentium leads to
an increase in production of keratinocyte growth factor (16),
which binds to its cognate receptor on epithelial cells, inducing
cell proliferation (2).
In conclusion, we have shown that lifA/efa1 plays a role in
the systemic manifestations of enteric infection with C. roden-
tium. Further, lifA/efa1 positively regulates epithelial cell pro-
liferation, colonic inflammation, and the development of
TMCH. lifA/efa1 is the first gene outside the LEE island that
plays a critical role in the pathogenesis of C. rodentium infec-
tion.
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